Search

everythinglearnresearchcommunity

for

Search:↓

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The gene for slick hair in Senepol cattle is located on chromosome 20 and may involve the SRD5A2 gene.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Formononetin, found in red clover, may treat hair loss with fewer side effects.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Some skin diseases and their treatments can negatively affect male fertility.

Various treatments exist for hair loss, but more research is needed for better options.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

EF and PXE not closely related.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

The best treatment for male pattern baldness is a combination of topical minoxidil and oral finasteride.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.